These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37924341)

  • 41. Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation.
    Sun Y; Hu H; Liu Z; Xu J; Gao Y; Zhan X; Zhou S; Zhong W; Wu D; Wang P; Rao Z; Kong L; Zhou H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36927529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive
    Peplau E; De Rose F; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; Skerra A; D'Alessandria C
    Thyroid; 2020 Sep; 30(9):1314-1326. PubMed ID: 32200708
    [No Abstract]   [Full Text] [Related]  

  • 43. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-step
    Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
    Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [
    Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
    Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomography.
    Viertl D; Bischof Delaloye A; Lanz B; Poitry-Yamate C; Gruetter R; Mlynarik V; Ametamey SM; Ross TL; Lehr HA; André PA; Perillo-Adamer F; Kosinski M; Dupertuis YM; Buchegger F
    Mol Imaging Biol; 2011 Apr; 13(2):321-31. PubMed ID: 20556524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs.
    Ohtsukasa S; Okabe S; Yamashita H; Iwai T; Sugihara K
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):719-26. PubMed ID: 14564514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
    Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
    Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 50. Immuno-PET Monitoring of CD8
    Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
    Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with
    Qin S; Yu Y; Guan H; Yang Y; Sun F; Sun Y; Zhu J; Xing L; Yu J; Sun X
    Aging (Albany NY); 2021 Apr; 13(9):13006-13022. PubMed ID: 33910164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preclinical
    Balber T; Singer J; Berroterán-Infante N; Dumanic M; Fetty L; Fazekas-Singer J; Vraka C; Nics L; Bergmann M; Pallitsch K; Spreitzer H; Wadsak W; Hacker M; Jensen-Jarolim E; Viernstein H; Mitterhauser M
    Contrast Media Mol Imaging; 2018; 2018():1269830. PubMed ID: 29666562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel aliphatic 18F-labeled probe for PET imaging of melanoma.
    Liu H; Liu S; Miao Z; Jiang H; Deng Z; Hong X; Cheng Z
    Mol Pharm; 2013 Sep; 10(9):3384-91. PubMed ID: 23927458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical evaluation of a dual-receptor targeted tracer [
    Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
    McKnight BN; Viola-Villegas NT
    Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
    Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
    J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Al
    Liu F; Zhao B; Xia XT; Yan JR; Yu FQ; Yan GP; Hu J; Chen S; Wang YF; Liu H; Lan XL; Zhang YX
    J Cell Biochem; 2019 Oct; 120(10):17006-17014. PubMed ID: 31131464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma.
    Harabuchi S; Kosaka A; Yajima Y; Nagata M; Hayashi R; Kumai T; Ohara K; Nagato T; Oikawa K; Ohara M; Harabuchi Y; Ohkuri T; Kobayashi H
    Biochem Biophys Res Commun; 2020 Feb; 522(2):408-414. PubMed ID: 31771883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micro-positron emission tomography imaging of angiogenesis based on
    Zhang MY; Jiang HJ; Jiang H; Zhang RJ; Wang ZC
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):345-351. PubMed ID: 33753000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models.
    Morelli MP; Tentler JJ; Kulikowski GN; Tan AC; Bradshaw-Pierce EL; Pitts TM; Brown AM; Nallapareddy S; Arcaroli JJ; Serkova NJ; Hidalgo M; Ciardiello F; Eckhardt SG
    Clin Cancer Res; 2012 Feb; 18(4):1051-62. PubMed ID: 22173548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.